LIPA and cancer: In contrast to the anti-inflammatory role of PPARγ in IL-4-polarized macrophages, the enhanced PPARγ signalling in cancer-associated PMN-MDSCs decreases the lysosomal acid lipase (LAL), generating reduced ROS production and impairing cancer cell proliferation and metastasis [169].